» Articles » PMID: 24925083

Inference About the Expected Performance of a Data-driven Dynamic Treatment Regime

Overview
Journal Clin Trials
Publisher Sage Publications
Date 2014 Jun 14
PMID 24925083
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A dynamic treatment regime (DTR) comprises a sequence of decision rules, one per stage of intervention, that recommends how to individualize treatment to patients based on evolving treatment and covariate history. These regimes are useful for managing chronic disorders, and fit into the larger paradigm of personalized medicine. The Value of a DTR is the expected outcome when the DTR is used to assign treatments to a population of interest.

Purpose: The Value of a data-driven DTR, estimated using data from a Sequential Multiple Assignment Randomized Trial, is both a data-dependent parameter and a non-smooth function of the underlying generative distribution. These features introduce additional variability that is not accounted for by standard methods for conducting statistical inference, for example, the bootstrap or normal approximations, if applied without adjustment. Our purpose is to provide a feasible method for constructing valid confidence intervals (CIs) for this quantity of practical interest.

Methods: We propose a conceptually simple and computationally feasible method for constructing valid CIs for the Value of an estimated DTR based on subsampling. The method is self-tuning by virtue of an approach called the double bootstrap. We demonstrate the proposed method using a series of simulated experiments.

Results: The proposed method offers considerable improvement in terms of coverage rates of the CIs over the standard bootstrap approach.

Limitations: In this article, we have restricted our attention to Q-learning for estimating the optimal DTR. However, other methods can be employed for this purpose; to keep the discussion focused, we have not explored these alternatives.

Conclusion: Subsampling-based CIs provide much better performance compared to standard bootstrap for the Value of an estimated DTR.

Citing Articles

Estimation and inference on high-dimensional individualized treatment rule in observational data using split-and-pooled de-correlated score.

Liang M, Choi Y, Ning Y, Smith M, Zhao Y J Mach Learn Res. 2023; 23.

PMID: 38098839 PMC: 10720606.


Deeply Tailored Adaptive Interventions to Reduce College Student Drinking: a Real-World Application of Q-Learning for SMART Studies.

Lyden G, Vock D, Sur A, Morrell N, Lee C, Patrick M Prev Sci. 2022; 23(6):1053-1064.

PMID: 35543888 PMC: 9357163. DOI: 10.1007/s11121-022-01371-7.


A SMART approach to optimizing delivery of an mHealth intervention among cancer survivors with posttraumatic stress symptoms.

Smith S, Somers T, Kuhn E, Laber E, Sung A, Syrjala K Contemp Clin Trials. 2021; 110:106569.

PMID: 34536584 PMC: 8595815. DOI: 10.1016/j.cct.2021.106569.


Evaluating the Effectiveness of Personalized Medicine With Software.

Kapelner A, Bleich J, Levine A, Cohen Z, DeRubeis R, Berk R Front Big Data. 2021; 4:572532.

PMID: 34085036 PMC: 8167073. DOI: 10.3389/fdata.2021.572532.


Optimal individualized decision rules using instrumental variable methods.

Qiu H, Carone M, Sadikova E, Petukhova M, Kessler R, Luedtke A J Am Stat Assoc. 2021; 116(533):174-191.

PMID: 33731969 PMC: 7959164. DOI: 10.1080/01621459.2020.1745814.


References
1.
Murphy S . A Generalization Error for Q-Learning. J Mach Learn Res. 2006; 6:1073-1097. PMC: 1475741. View

2.
Zhang B, Tsiatis A, Laber E, Davidian M . Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions. Biometrika. 2013; 100(3). PMC: 3843953. DOI: 10.1093/biomet/ast014. View

3.
Shortreed S, Moodie E . Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study. J R Stat Soc Ser C Appl Stat. 2012; 61(4):577-599. PMC: 3475611. DOI: 10.1111/j.1467-9876.2012.01041.x. View

4.
Tummarello D, Mari D, Graziano F, Isidori P, Cetto G, Pasini F . A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma.... Cancer. 1997; 80(12):2222-9. View

5.
Chakraborty B, Laber E, Zhao Y . Inference for optimal dynamic treatment regimes using an adaptive m-out-of-n bootstrap scheme. Biometrics. 2013; 69(3):714-23. PMC: 3864701. DOI: 10.1111/biom.12052. View